Venture Life Group (LON:VLG – Get Free Report) released its earnings results on Tuesday. The company reported GBX 4.10 earnings per share for the quarter, Digital Look Earnings reports. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.
Venture Life Group Stock Up 3.8%
Venture Life Group stock traded up GBX 2.50 during trading hours on Thursday, hitting GBX 68. The company had a trading volume of 1,257,794 shares, compared to its average volume of 278,098. Venture Life Group has a fifty-two week low of GBX 52 and a fifty-two week high of GBX 72. The company has a debt-to-equity ratio of 0.82, a current ratio of 4.71 and a quick ratio of 1.48. The firm has a market capitalization of £81.63 million, a P/E ratio of 15.56, a price-to-earnings-growth ratio of 5.67 and a beta of 0.23. The firm’s fifty day moving average is GBX 67.41 and its 200-day moving average is GBX 65.09.
Insider Buying and Selling at Venture Life Group
In other news, insider Daniel Wells acquired 38,717 shares of the business’s stock in a transaction that occurred on Wednesday, September 30th. The stock was acquired at an average cost of GBX 65 per share, for a total transaction of £25,166.05. Company insiders own 7.52% of the company’s stock.
About Venture Life Group
Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.
Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.
Recommended Stories
- Five stocks we like better than Venture Life Group
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.
